Zion, Illinois Clinical Trials

A listing of Zion, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 117 clinical trials
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight

This is a study of tirzepatide in participants with type 2 diabetes who have obesity or are overweight. The main purpose is to learn more about how tirzepatide affects body weight. The study will last 79 weeks (22 visits).

glucagon
glucagon-like peptide-1
hemoglobin a1c
diabetes
Clinical Investigation Specialists
 (7.9 away) Contact site
  • 35 views
  • 26 Sep, 2021
  • +92 other locations
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

The main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery. Participants must have breast cancer that is hormone receptor positive (HR+) and human epidermal receptor 2 positive (HER2+). Your participation could last up to …

invasive breast cancer
HER2
erbb2
trastuzumab
pertuzumab
Cancer Treatment Centers of America
 (0.0 away) Contact site
  • 0 views
  • 26 Sep, 2021
  • +569 other locations
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

The purpose of this study is to evaluate the efficacy and safety of nipocalimab in participants with primary Sjogren's syndrome (pSS) versus placebo.

rheumatism
Clinical Investigation Specialists
 (6.9 away) Contact site
  • 0 views
  • 09 Sep, 2021
  • +35 other locations
A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD).

alzheimer's disease
amyloid
Great Lakes Clinical Trials - Gurnee
 (6.9 away) Contact site
  • 1 views
  • 26 Sep, 2021
  • +72 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

atezolizumab
mmr protein
tumor cells
colon cancer
pulmonary disease
Aurora Cancer Care-Kenosha South
 (7.9 away) Contact site
  • 1047 views
  • 26 Sep, 2021
  • +595 other locations
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

The main purpose of this study is to learn if the usual chemotherapy given before surgery (neoadjuvant therapy) for breast cancer plus the experimental drug, atezolizumab, is better than the usual chemotherapy plus a placebo. (A placebo is a drug that looks like the study drug but contains no medication.) …

atezolizumab
HER2
erbb2
core needle biopsy
mastectomy
Aurora Cancer Care-Kenosha South
 (7.9 away) Contact site
  • 1000 views
  • 21 Apr, 2021
  • +234 other locations
Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

This is a Phase 2, open-label, multi-center study to evaluate the efficacy and the safety/tolerability of poziotinib in seven patient cohorts for up to 603 previously treated and treatment-nave NSCLC patients. Cohorts 3 and 4 were added with Amendment 1 and three additional cohorts were added with Amendment 2 (Cohorts …

HER2
erbb2
osimertinib
EGFR
cancer chemotherapy
CTCA - Midwestern Regional Medical Center
 (0.0 away) Contact site
  • 320 views
  • 12 Sep, 2021
  • +70 other locations
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does …

lymphoma
ct scan
vasectomy
neutrophil count
multiple myeloma
Cancer Treatment Centers of America-Chicago
 (0.0 away) Contact site
  • 0 views
  • 03 Sep, 2021
  • +75 other locations
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with enzalutamide.

Midwestern Regional Medical Center
 (0.0 away) Contact site
  • 4301 views
  • 26 Sep, 2021
  • +515 other locations
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming …

HER2
erbb2
core needle biopsy
adjuvant chemotherapy
tamoxifen
Aurora Cancer Care-Kenosha South
 (7.9 away) Contact site
  • 598 views
  • 23 Sep, 2021
  • +323 other locations